Bitan G, Scheibler L, Greenberg Z, Rosenblatt M, Chorev M
Division of Bone and Mineral Metabolism, Charles A. Dana and Thorndike Laboratories, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
Biochemistry. 1999 Mar 16;38(11):3414-20. doi: 10.1021/bi981946c.
Integrins are cell surface adhesion molecules involved in mediating cell-extracellular matrix interactions. High-resolution structural data are not available for these heterodimeric receptors. Previous cross-linking studies of integrins aimed at elucidating the nature of the receptor-ligand interface have been limited to identification of relatively large binding domains. To create reagents for "photoaffinity scanning" of the RGD-binding site of human integrin alpha V beta 3, new conformationally constrained ligands were designed. These photoreactive ligands are based on cyclo Ac-[Cys-Asn-Dmt-Arg-Gly-Asp-Cys]-OH, which displays an affinity of 50 nM for alpha V beta 3. This molecular scaffold was modified at the C-terminus by a benzophenone-containing amino acid residue, L-4-benzoylphenylalanine (Bpa). At the N-terminus, a molecular tag was introduced in the form of radioactive iodine or biotin. The newly designed tagged photoreactive RGD-containing ligands display an affinity of 0.5-0.7 microM for alpha V beta 3, and cross-link efficiently and specifically to the receptor. A 100 kDa band corresponding to the beta 3 subunit-ligand conjugate was detected as the major cross-linking product. Cross-linking was dependent upon the presence of Ca2+ and Mg2+ ions, and was competitively inhibited by a nonphotoreactive ligand. Enzymatic and chemical digestions of the radiolabeled photoconjugate enabled identification of a 20-amino acid fragment between positions 99 and 118 in the beta 3 chain of the integrin as the contact domain for ligand at a site adjacent to the C-terminal portion of the RGD triad.
整合素是参与介导细胞与细胞外基质相互作用的细胞表面粘附分子。目前尚无这些异二聚体受体的高分辨率结构数据。先前针对阐明整合素受体-配体界面性质的交联研究仅限于鉴定相对较大的结合结构域。为了创建用于对人整合素αVβ3的RGD结合位点进行“光亲和扫描”的试剂,设计了新的构象受限配体。这些光反应性配体基于环Ac-[Cys-Asn-Dmt-Arg-Gly-Asp-Cys]-OH,其对αVβ3的亲和力为50 nM。该分子支架在C端通过含二苯甲酮的氨基酸残基L-4-苯甲酰基苯丙氨酸(Bpa)进行修饰。在N端,以放射性碘或生物素的形式引入了分子标签。新设计的带有标签的光反应性含RGD配体对αVβ3的亲和力为0.5-0.7μM,并能有效且特异性地与受体交联。检测到一条对应于β3亚基-配体缀合物的100 kDa条带作为主要交联产物。交联依赖于Ca2+和Mg2+离子的存在,并受到非光反应性配体的竞争性抑制。对放射性标记的光共轭物进行酶解和化学消化,可鉴定出整合素β3链中第99至118位之间的一个20个氨基酸片段作为配体在RGD三联体C端部分相邻位点的接触结构域。